Tamoxifen from Failed Contraceptive Pill to Best-Selling Breast Cancer Medicine: A Case-Study in Pharmaceutical Innovation
Crossref DOI link: https://doi.org/10.3389/fphar.2017.00620
Published Online: 2017-09-12
Update policy: https://doi.org/10.3389/crossmark-policy
Quirke, Viviane M.
Funding for this research was provided by:
Wellcome Trust (09568/Z/11/A, 086843/Z/08/Z)